// STATE LEGISLATION TRACKER

California AB 2442 — Peptides.

⚖️ MIXED for peptide users 👤 LOW user impact 📜 Status: In committee

State: California
Bill: AB 2442
Filed: 2026-02-20
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

AB 2442 would create a California Department of Public Health working group to study peptides and novel investigational compounds and recommend a state framework by January 1, 2029. As amended, it does not currently legalize new peptide access, expand prescribing, change compounding rules, or create a retail pathway for patients.

Key Points

No immediate new patient access to peptides is created
The bill studies a future state-regulated peptide framework
Current text does not change 503A or 503B compounding rules
No telehealth, NP, or naturopath scope expansion is stated
Novel compounds tied to controlled substances are outside the framework

What to Watch For

✓

Opportunity Future recommendations could support regulated access for investigational peptides under medical supervision.

Concern Later versions could add restrictions, reporting, or institutional controls that raise access barriers.

Note The current bill is mainly a study-and-report bill, not an access or prescribing bill.

Concern NPs, naturopaths, and telehealth peptide clinics are not clearly included in the current framework.

Where the Bill Stands

As of May 6, 2026, AB 2442 was in the Assembly Appropriations Committee suspense file after earlier committee approvals.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws